NM_003977.4:c.166C>T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_003977.4(AIP):c.166C>T(p.Arg56Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000744 in 1,613,956 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_003977.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AIP | NM_003977.4 | c.166C>T | p.Arg56Cys | missense_variant | Exon 2 of 6 | ENST00000279146.8 | NP_003968.3 | |
AIP | NM_001302959.2 | c.-12C>T | 5_prime_UTR_premature_start_codon_gain_variant | Exon 2 of 6 | NP_001289888.1 | |||
AIP | NM_001302960.2 | c.166C>T | p.Arg56Cys | missense_variant | Exon 2 of 6 | NP_001289889.1 | ||
AIP | NM_001302959.2 | c.-12C>T | 5_prime_UTR_variant | Exon 2 of 6 | NP_001289888.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152202Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 251360Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135914
GnomAD4 exome AF: 0.00000753 AC: 11AN: 1461754Hom.: 0 Cov.: 32 AF XY: 0.00000688 AC XY: 5AN XY: 727172
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152202Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74338
ClinVar
Submissions by phenotype
not provided Uncertain:2
This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 56 of the AIP protein (p.Arg56Cys). This variant is present in population databases (rs267606538, gnomAD 0.007%). This missense change has been observed in individual(s) with pituitary macroadenoma (PMID: 21753072). ClinVar contains an entry for this variant (Variation ID: 877266). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt AIP protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 23371967, 21753072, 37711900, 37956455) -
Somatotroph adenoma Uncertain:1
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -
Hereditary cancer-predisposing syndrome Uncertain:1
The p.R56C variant (also known as c.166C>T), located in coding exon 2 of the AIP gene, results from a C to T substitution at nucleotide position 166. The arginine at codon 56 is replaced by cysteine, an amino acid with highly dissimilar properties. This alteration was identified in an individual diagnosed with a prolactinoma (Tichomirowa MA et al. Eur J Endocrinol, 2011 Oct;165:509-15). This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at